Home The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease
Article
Licensed
Unlicensed Requires Authentication

The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease

  • Amalia Papanikolopoulou , Olfert Landt , Konstantinos Ntoumas , Stefanos Bolomitis , Stavros I. Tyritzis , Constantinos Constantinides and Nikolaos Drakoulis EMAIL logo
Published/Copyright: November 14, 2011

Abstract

Background: Recently, several polymorphisms located on human chromosome 8q24 were found to be associated with prostate cancer risk with different frequency and incidence among the investigated populations. The authors conducted a prostate cancer case-control study in the Greek population to evaluate the association of the single nucleotide polymorphism (SNP) rs6983267, located at region 3 of chromosome 8q24, with this type of cancer.

Methods: Samples of total blood from 86 patients with histologically confirmed prostate cancer and 99 healthy individuals were genotyped using real time polymerase chain reaction (PCR). Tumor-node-metastasis (TNM) stage, Gleason score and levels of prostate-specific antigen (PSA) at diagnosis were included in the analysis.

Results: A highly significant association (odds ratio=2.84 and p-value=0.002) was found between rs6983267 and prostate cancer in the Greek population. The sensitivity, specificity, negative and positive predictive values of the presence of G allele for the discrimination between patients and controls were 81.40%, 39.4%, 53.9% and 70.9%, respectively. A lower proportion of homozygotes was found in patients with PSA level <4 ng/mL compared to those with PSA level more than 4 ng/mL (p=0.019). None of the other clinical factors nor the aggressiveness of the disease were found to be significantly associated with rs6983267 genotype.

Conclusions: The SNP rs6983267 is an established marker for a range of cancers. In prostate cancer, it indicates an enhanced risk for carriers to develop the disease in general. In our study it showed no association with aggressive forms or familial and early-onset prostate cancer families.


Corresponding author: Nikolaos Drakoulis, Department of Pharmaceutical Technology, School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece Phone: +30 210 9948200, Fax: +30 210 9948209

Received: 2011-5-27
Accepted: 2011-10-11
Published Online: 2011-11-14
Published in Print: 2012-02-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorials
  2. Biological variation and reference change values: an essential piece of the puzzle of laboratory testing
  3. Copeptin for acute coronary syndrome: diamond or decoy?
  4. Reviews
  5. Gold nanoparticles in the clinical laboratory: principles of preparation and applications
  6. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
  7. Mini Review
  8. From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach
  9. Opinion Paper
  10. Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin
  11. Perspectives
  12. Do genome-wide association scans have potential for translation?
  13. Genetics and Molecular Diagnostics
  14. Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma
  15. Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue
  16. Screening for mutations in the α-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis
  17. Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene
  18. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) –482C>T polymorphism on triglyceride concentration in Turkish adults
  19. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients
  20. Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods
  21. Functional polymorphisms of GSTA1 and GSTO2 genes associated with asthma in Italian children
  22. General Clinical Chemistry and Laboratory Medicine
  23. Optimisation of whole blood and plasma manganese assay by ICP-MS without use of a collision cell
  24. Quantitative performance of antibody array technology in a prenatal screening setting
  25. A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption
  26. A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency
  27. Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren’s syndrome patients
  28. Development of control material for hemoglobin analysis
  29. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases
  30. The effect of hematocrit on the results of measurements using glucose meters based on different techniques
  31. Lupus anticoagulant testing: analyzing fresh samples after a single centrifugation and after a 6–8 h delay
  32. Pseudoeosinophilia of synovial fluid is caused by crystals mimicking the distinct light scattering fractions of eosinophilic granules
  33. The effect of acidification and oxalate concentration on urine calcium measurements in EQAS materials and patient samples
  34. Cancer Diagnostics
  35. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease
  36. Cardiovascular Diseases
  37. Heart type fatty acid binding protein in relation to pharmacologic scintigraphy in coronary artery disease
  38. Effects of fibrates on C-reactive protein concentrations: a meta-analysis of randomized controlled trials
  39. Letters to the Editor
  40. Comparison of Bio-Plex measurements with standard techniques
  41. Interference of hemoglobin (Hb) Las Palmas with HPLC measurement of HbA1c in 87 patients
  42. False-positive calcitonin results in patients with benign goiter
  43. Erratum
  44. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  45. Congress Abstracts
  46. Advances and Controversies in B-Vitamins and Choline
  47. Prelims
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.778/html
Scroll to top button